Hong Liang

27PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCheminformatics and quantitative structure-activity relationshipsChemotherapyBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jun 25, 2026
GPX4-Targeting Phenolato Zr<sup>IV</sup> Complexes Induce Ferroptosis and Lysosome-Dependent Cell Death for Immunotherapy of Chemoresistant Cancer.

|Jun 11, 2026
Pt(IV) Complexes Incorporating CDC25A/NF-κB Dual Inhibitory 1,4-Naphthoquinone Derivatives Trigger Multimodal Cell Death in A2780 Ovarian Cancer Cells.

|May 05, 2026
Discovery of a Novel Tetrahydro-β-Carboline Mcl-1 Inhibitor with Antitumor Activity and Capability to Overcome Cisplatin Resistance.

|Apr 21, 2026
Activation of Synergistic Ferroptosis and Apoptosis by a Cu(II) Complex through Concurrent Amplification of Endoplasmic Reticulum Stress and Mitochondrial Dysfunction.

|Mar 30, 2026
Oxoisoaporphine Alkaloid Piano-Stool Arene Ruthenium(II) Derivative: A cGAS-STING-Mediated Chemoimmunotherapy Inducer that Acts as a Dual Catalytic Inhibitor of Topoisomerase I/II.

Liang-Mei Yang, Yuan Lu, Matthew S Levine

|Mar 13, 2026
The First Multimodal Anticancer Manganese(II) Complex of an Asymmetric Anthrahydrazone Triggers Apoptosis, Autophagy and Ferroptosis.

Rui-Xue Liu, Dong-Mei Li, Ru-Yi Luo

Pageof 5

Frequent Collaborators

6 joint publications

Fu-Ping Huang

4 joint publications

Liangliang Zhang

4 joint publications

Changchun Wen

4 joint publications

Xing-Can Shen